Search Site

Linda J. Addonizio, MD

  • Professor of Pediatrics at CUMC
  • Director, Program for Pediatric Cardiomyopathy, Heart Failure and Transplantation
Linda J. Addonizio, MD

Dr. Addonizio began the Pediatric Cardiac Transplant Program in 1984 and presently directs the Program for Pediatric Cardiomyopathy, Heart Failure and Transplantation. This program offers comprehensive multidisciplinary care to children from all over the world who have complex heart disease and / or are at high risk for transplantation. She is also part of the Columbia Muscular Dystrophy Association Clinic and the New York Presbyterian Columbia University Medical Center Cardiogenetics Program. Her research is in the area of transplantation, cardiomyopathy and heart failure in children.

Education & Training

  • Columbia University College of Physicians and Surgeons
  • BS, 1974 Stanford University
  • MD, 1978 Columbia University College of Physicians and Surgeons
  • Residency: Babies & Children's Hospital - Columbia Presbyterian Medical Center
  • Fellowship: Babies & Children's Hospital - Columbia Presbyterian Medical Center

Honors & Awards

  • Rustin McIntosh Award
  • Elected to Board of Directors of International Society of Heart and Lung Transplantation
  • Governor's Award for Excellence as a Woman in History

Research Interests

  • Pediatric Cardiology
  • Pediatric Heart Failure and Cardiomyopathy
  • Pediatric Heart Transplantation
  • Secondary Pulmonary Hypertension

NIH Grants

  • CARDIAC BIOMARKERS IN PEDIATRIC CARDIOMYOPATH (PER PATIENT) (Federal Gov)

    Apr 1 2014 - Jun 30 2019

    CHRONIC GRAFT DESTRUCTION: INTERPLAY OF ALLO- AND AUTOANTIBODIES AND NONADHERENCE (Federal Gov)

    May 1 2016 - Jan 31 2019

    MULTICENTER RANDOMIZED TRIAL OF EVEROLIMUS IN PEDIATRIC HEART TRANSPLANTATION (Federal Gov)

    Sep 15 2017 - Sep 14 2018

    QUALITY OF LIFE ASSESSMENT IN THE PEDIATRIC CARDIAC POPULATION: TESTING THE PEDIATRIC CARDIAC QUALITY OF LIFE INVENTORY ( STUDY ) (Private)

    Jun 1 2017 - May 31 2018

    GENOTYPE-PHENOTYPE ASSOCIATIONS IN PEDIATRIC CARDIOMYOPATHY (Federal Gov)

    Apr 1 2015 - Mar 31 2018

    GENOTYPE-PHENOTYPE ASSOC. IN PEDIATRIC CARDIOMYOPATHY NON-FED (Private)

    Oct 1 2014 - Sep 30 2017

    GENOTYPE-PHENOTYPE ASSOCIATIONS IN PEDIATRIC CARDIOMYOPATHY (Federal Gov)

    Apr 1 2015 - Mar 31 2017

    CHRONIC GRAFT DESTRUCTION INTERPLAY OF ALIO AND AUTOANTIBODIES AND NONADHERENCE (Federal Gov)

    Feb 1 2013 - Jan 31 2016

    GENOTYPE-PHENOTYPE ASSOC. IN PEDIATRIC CARDIOMYOPATHY NON-FED (Private)

    Oct 1 2014 - Sep 30 2015

    GENOTYPE-PHENOTYPE ASSOC. IN PEDIATRIC CARDIOMYOPATHY FED (Federal Gov)

    Apr 1 2014 - Jun 30 2015

    B-CELL TARGETED INDUCTION TO IMPROVE OUTCOMES IN PEDIATRIC LUNG TRANSPLANTATION (Federal Gov)

    Mar 1 2014 - Feb 28 2015

    CARDIAC BIOMARKERS IN PEDIATRIC CARDIOMYOPATHY (Federal Gov)

    Aug 6 2012 - Jul 31 2014

    PEDIATRIC HEART TRANSPLANTATION: TRANSITIONING TO ADULT CARE (Federal Gov)

    Jul 15 2013 - May 31 2014

    GENOTYPE-PHENOTYPE ASSOCIATIONS IN PEDIATRIC CARDIOMYOPATHY NON-FED (Private)

    Apr 1 2012 - Mar 31 2014

    GENOTYPE-PHENOTYPE ASSOCIATIONS IN PEDICATRIC CARDIOMYOPATHY FED (Federal Gov)

    Apr 1 2012 - Mar 31 2014

    VIRAL TRIGGERS OF ALLOIMMUNITY AND AUTOIMMUNITY IN PEDIATRIC LUNG TRANSPLANTATION (Federal Gov)

    Sep 17 2010 - Jun 30 2013

    ALLOANTIBODIES IN CARDIAC TRANSPLANTATION-INTERVENTION, OUTCOMES, AND MECHANISMS (Federal Gov)

    Sep 1 2012 - Feb 28 2013

    ALLANTIBODIES IN CARDIAC TRANSPLANTATION - INTERVENTION, OUTCOMES AND MECHANISMS (Federal Gov)

    Mar 1 2012 - Aug 31 2012

    ALLANTIBODIES IN CARDIAC TRANSPLANTATION - INTERVENTION, OUT COMES AND MECHANISMS (Federal Gov)

    Mar 1 2009 - Feb 29 2012

    PEDIATRIC CARDIOMYOPATHY REGISTRY (Federal Gov)

    Mar 31 2004 - May 31 2010

    PEDIATRIC CARDIOMYOPATHY REGISTRY (Federal Gov)

    Mar 1 2004 - May 31 2010

    OPTIMIZING OUTCOMES AFTER PEDIATRIC HEART TRANSPLANTATION (Federal Gov)

    Feb 15 2004 - Jan 31 2009